1 |
mRNA of adenylyl cyclases in DRG and spinal cord |
Systemic morphine or saline twice daily for 5 days (15 mg/kg, sc) |
N/A |
2 |
ST034307 Mechanical and thermal antinociception |
Vehicle or ST034307 (2.5–10 mg/kg, ip, 100 µl) 15 min post-morphine |
Von frey and thermal paw withdrawal |
3 |
ST034307 Escalating morphine tolerance |
Systemic morphine twice daily for 5 days (10 mg/kg on day 1 increasing to 40 mg/kg by day 4, sc, 100µl) + vehicle or ST034307 (2.5–10 mg/kg, ip, 100 µl) 15 min post-morphine, vehicle or ST034307 (2.5–10 mg/kg, ip, 100 µl) on Day 5 |
Von frey paw withdrawal |
4 |
AC1 knockdown via intrathecal delivery: morphine antinociception |
AAV9-Adcy1-shRNA or AAV9-Scrambl-shRNA delivered intrathecally, morphine doses 5–20 mg/kg, sc, measurements taken 30 min after morphine injection |
Von frey paw withdrawal |
5 |
AC1 knockdown via intrathecal delivery: escalating morphine tolerance |
AAV9-Adcy1-shRNA or AAV9-Scrambl-shRNA delivered intrathecally, Twice daily escalating injections of morphine (10 mg/kg on day 1 increasing to 40 mg/kg by day 4, sc, 100 µl) |
Von frey paw withdrawal |
6 |
AC1 knockdown via intrathecal delivery: morphine tolerance |
AAV9-Adcy1-shRNA or AAV9-Scrambl-shRNA delivered intrathecally, twice daily injections of morphine for 5 days (15 mg/kg, sc) |
Von frey paw withdrawal |
7 |
AC1 knockdown via intrathecal delivery: CFA model of inflammatory pain |
AAV9-Adcy1-shRNA or AAV9-Scrambl-shRNA delivered intrathecally, CFA delivered intraplantar (one hindpaw) |
Before CFA: Rotarod performance test, open field testing, thermal paw withdrawal testing, Von frey paw withdrawal (baseline) after CFA: Von frey paw withdrawal. burrowing testing, nesting |